Melissa Pilewskie

ORCID: 0000-0003-0508-6424
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Breast Cancer Treatment Studies
  • Breast Lesions and Carcinomas
  • BRCA gene mutations in cancer
  • Cancer Risks and Factors
  • Global Cancer Incidence and Screening
  • HER2/EGFR in Cancer Research
  • Breast Implant and Reconstruction
  • Cancer Genomics and Diagnostics
  • Radiomics and Machine Learning in Medical Imaging
  • Estrogen and related hormone effects
  • Nutrition, Genetics, and Disease
  • Cancer Treatment and Pharmacology
  • MRI in cancer diagnosis
  • Cancer Diagnosis and Treatment
  • Advanced Breast Cancer Therapies
  • Medical Imaging Techniques and Applications
  • Metabolism, Diabetes, and Cancer
  • AI in cancer detection
  • Bioinformatics and Genomic Networks
  • Cancer, Lipids, and Metabolism
  • Multiple and Secondary Primary Cancers
  • Colorectal Cancer Screening and Detection
  • Pain Management and Opioid Use
  • Nausea and vomiting management
  • Prenatal Screening and Diagnostics

University of Michigan
2022-2025

Michigan Medicine
2024-2025

Memorial Sloan Kettering Cancer Center
2015-2024

Northwestern University
2011-2019

IIT Research Institute
2019

National Institutes of Health
2019

Cedars-Sinai Medical Center
2019

Case Western Reserve University
2019

European Neuroendocrine Tumor Society
2018

American College of Surgeons
2015-2017

Purpose The increased breast cancer risk conferred by a diagnosis of lobular carcinoma in situ (LCIS) is poorly understood. Here, we review our 29-year longitudinal experience with LCIS to evaluate factors associated risk. Patients and Methods participating surveillance after an are observed prospectively maintained database. Comparisons were made among women choosing surveillance, or without chemoprevention, those undergoing bilateral prophylactic mastectomies between 1980 2009. Results One...

10.1200/jco.2015.61.4743 article EN Journal of Clinical Oncology 2015-09-15

Prospective trials have demonstrated sentinel lymph node (SLN) false-negative rates of less than 10% when 3 or more SLNs are retrieved in patients with clinically node-positive breast cancer rendered node-negative neoadjuvant chemotherapy (NAC). However, nodal recurrence such treated SLN biopsy (SLNB) alone unknown because axillary dissection (ALND) was performed all patients, limiting adoption this approach.To evaluate a consecutive cohort (cN1) receiving NAC, followed by negative SLNB...

10.1001/jamaoncol.2021.4394 article EN JAMA Oncology 2021-10-10

Abstract Background Racial disparities in breast cancer survival between Black and White women persist across all stages of cancer. The metabolic syndrome (MetS) insulin resistance disproportionately affects more than women. It has not been discerned if mediates the link race poor prognosis We aimed to determine whether part association prognosis, receptor (IR) insulin-like growth factor (IGF-1R) expression differs tumors from Methods conducted a cross-sectional, multi-center study ten...

10.1186/s13058-020-01281-y article EN cc-by Breast Cancer Research 2020-05-11

Abstract Background: In patients with micro- and macrometastases in the sentinel lymph node (SLN) after neoadjuvant chemotherapy (NAC), additional positive nodes are found >60% of cases axillary dissection (ALND) is currently considered standard care. The likelihood finding residual isolated tumor cells (ITCs) unknown, benefit ALND unclear. As a consequence, surgical management axilla these not standardized. We sought to evaluate how often found, determine factors associated ALND,...

10.1158/1538-7445.sabcs23-gs02-02 article EN Cancer Research 2024-05-02
Giacomo Montagna Alison Laws Massimo Ferrucci Mary Mrdutt Susie X. Sun and 95 more Süleyman Bademler Hakan Balbaloğlu Nora Balint‐Lahat Malgorzata Banys-Paluchowski Andrea V. Barrio John R. Benson Nuran Beşe Judy C. Boughey Marissa K. Boyle Emilia J. Diego Claire Eden Ruth Eller Maite Goldschmidt Callie Hlavin Martin Heidinger Justyna Jelinska Güldeniz Karadeniz Çakmak Susan B. Kesmodel Tari A. King Henry M. Kuerer Julie M Loesch Francesco Milardi Dawid Murawa Tracy‐Ann Moo Tehillah S. Menes Daniele Passeri Jessica Pastoriza Andraž Perhavec Nina Pislar Natália Polidorio Avina Rami Jai Min Ryu Alexandra Schulz Varadan Sevilimedu Mustafa Ümit Uğurlu Cihan Uras Annemiek K. E. van Hemert Stephanie M. Wong Tae-Kyung Yoo Jennifer Q. Zhang Hasan Karanlık Neslihan Cabıoğlu Marie-Jeanne T. F. D. Vrancken Peeters Monica Morrow William P. Weber Sung Gwe Ahn Mariacarla Andreozzi Daniel Meirelles Barbalho J.-F. Boileau Edi Brogi Flávia Vidal Cabero Daniela Cocco Fabio Corsi Angelena Crown Eelco de Bree M. Vernet-Tomás Christine Deutschmann Nina Ditsch Emanuela Esposito Oluwadamilola M. Fayanju Franziska Fick Florian Fitzal Meghan R. Flanagan Damiano Gentile Oreste ­Gentilini Anne Grabenstetter Mehmet Ali Gülçelik Jörg Heil Johannes Holtschmidt Natalia Krawczyk Thorsten Kühn Sherko Kümmel Cornelia Leo Mahmut Muslumanoglu Valentina Nekljudova Lisa A. Newman Melissa Pilewskie Nikiforita Poulakaki Fabian Riedel Nicola Rocco Freya Schnabel Christopher J. Schwartz Emily Siegel Colin Simonson Christian F. Singer Leonardo Ribeiro Soares Ekaterini Christina Tampaki Athanasios Tampakis Marios Konstantinos Tasoulis Christoph Tausch Cícero Úrban Astrid Botty van den Bruele Glenn Vergauwen Denise Vorburger Fredrik Wärnberg

The nodal burden of patients with residual isolated tumor cells (ITCs) in the sentinel lymph nodes (SLNs) after neoadjuvant chemotherapy (NAC) (ypN0i+) is unknown, and axillary management not standardized. We investigated rates additional positive (LNs) at node dissection (ALND) oncologic outcomes ypN0i+ treated without ALND.

10.1200/jco.24.01052 article EN Journal of Clinical Oncology 2024-11-07

To investigate the value of contrast-enhanced mammography (CEM) compared to full-field digital (FFDM) in screening breast cancer patients after breast-conserving surgery (BCS), this Health Insurance Portability and Accountability Act-compliant, institutional review board-approved retrospective, single-institution study included 971 CEM exams 541 asymptomatic treated with BCS who underwent between January 2013 November 2018. Histopathology, or at least a one-year follow-up, was used as...

10.3390/cancers12123495 article EN Cancers 2020-11-24

Abstract Background Nipple-sparing mastectomy is associated with a higher risk of skin-flap necrosis than conventional skin-sparing mastectomy. There are limited prospective data examining modifiable intraoperative factors that contribute to after nipple-sparing Methods Data on consecutive patients undergoing between April 2018 and December 2020 were recorded prospectively. Relevant variables documented by both breast plastic surgeons at the time surgery. The presence extent nipple and/or...

10.1093/bjs/znad107 article EN British journal of surgery 2023-05-13

Abstract Purpose. We conducted a mouse–human co-clinical trial to evaluate the biological efficacy of exercise therapy in breast cancer prevention. Materials and methods. In phase 1 randomized trial, 75 nonexercising women at high-risk were allocated receive (1:1 ratio): usual care or one three dose regimens: 75, 150, 300 minutes/week for 24 consecutive weeks. Biological was evaluated by changes epithelial cell proliferation (Ki67). Correlative proteomic analysis paired tissue plasma samples...

10.1158/1078-0432.ccr-24-4298 article EN Clinical Cancer Research 2025-04-04
Coming Soon ...